The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling-Reference-Cited by-同舟云学术

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

Published:2016-10-25 Issue:10 Volume:13 Page:e1002152
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Houben Rein M. G. J.,Dodd Peter J.^ORCID

Funder

Bill and Melinda Gates Foundation (US)

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference32 articles.

1. World Health Organisation. Global Tuberculosis Report 2015. Geneva: 2015. http://www.who.int/tb/publications/global_report/en/ (Accessed 23 September 2016)

2. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection;T Lillebaek;J Infect Dis,2002

3. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project;C Dye;JAMA: the journal of the American Medical Association,1999

4. Latent Mycobacterium tuberculosis infection;H Getahun;N Engl J Med,2015

5. World Health Organisation. Tuberculosis Fact Sheet 2015 [1st March 2016]. http://www.who.int/mediacentre/factsheets/fs104/en/

Cited by 1370 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principles of infectious diseases: Transmission, Diagnosis, Prevention and Control;International Encyclopedia of Public Health;2025

2. Adherence to preventive treatment for latent tuberculosis infection in close contacts of pulmonary tuberculosis patients: A cluster-randomized controlled trial in China;International Journal of Infectious Diseases;2024-10

3. Immunoproteomic discovery of Mycobacterium bovis antigens, including the surface lipoprotein Mpt83 as a T cell antigen useful for vaccine development;Vaccine;2024-10

4. Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis;Expert Opinion on Drug Safety;2024-09-04

5. A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors;Frontiers in Pharmacology;2024-09-02